Macquarie Group’s Asensus Surgical, Inc. ASXC Stock Holding History

Macquarie Group’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,300	Closed	-$33K	–	2408
2017 Q4	$33K	Buy	+1,300	New	+$40K	﹤0.01%	2081

Other funds holding ASXC

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Macquarie Group's ASXC Position: Q1 2018 in Review

Macquarie Group sold out of Asensus Surgical, Inc. (ASXC) in Q1 2018, closing a stake of 1,300 shares — an estimated $33K sold.

Macquarie Group first reported a position in ASXC in Q4 2017 and held it in 1 quarter. The position peaked at $33K in Q4 2017. 95 funds tracked by Wall St. Rank hold ASXC as of Q1 2018.

Macquarie Group reported no remaining Asensus Surgical, Inc. position as of Q1 2018 after selling out during the quarter.
Macquarie Group sold 1,300 Asensus Surgical, Inc. shares in Q1 2018, an estimated $33K.
Macquarie Group first reported a position in Asensus Surgical, Inc. in Q4 2017 and held it in 1 quarter.
Macquarie Group's Asensus Surgical, Inc. position peaked at $33K in Q4 2017.
95 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2018.

Based on Macquarie Group's 13F filing for Q1 2018, filed 11 May 2018.